InnoCan Pharma Corporation
INNO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.63M | 6.69M | 7.27M | 7.26M | 6.37M |
| Total Receivables | 1.30M | 944.00K | 787.00K | 730.00K | 1.09M |
| Inventory | 2.18M | 2.18M | 2.45M | 2.60M | 2.95M |
| Prepaid Expenses | 76.00K | 72.00K | 54.00K | 47.00K | 70.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 583.00K | 554.00K | 466.00K | 301.00K | 236.00K |
| Total Current Assets | 10.77M | 10.44M | 11.02M | 10.94M | 10.71M |
|
|
|||||
| Total Current Assets | 10.77M | 10.44M | 11.02M | 10.94M | 10.71M |
| Net Property, Plant & Equipment | 80.00K | 86.00K | 93.00K | 100.00K | 107.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.85M | 10.52M | 11.12M | 11.04M | 10.82M |
|
|
|||||
| Total Accounts Payable | 327.00K | 235.00K | 43.00K | 233.00K | 178.00K |
| Total Accrued Expenses | 794.00K | 734.00K | 599.00K | 599.00K | 713.00K |
| Short-term Debt | 452.00K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 3.00K | 7.00K |
| Total Finance Division Other Current Liabilities | 379.00K | 386.00K | 2.32M | 2.12M | 1.73M |
| Total Other Current Liabilities | 379.00K | 386.00K | 2.32M | 2.12M | 1.73M |
| Total Current Liabilities | 1.95M | 1.36M | 2.96M | 2.95M | 2.63M |
|
|
|||||
| Total Current Liabilities | 1.95M | 1.36M | 2.96M | 2.95M | 2.63M |
| Long-Term Debt | 966.00K | 930.00K | 1.52M | 1.39M | 1.30M |
| Short-term Debt | 452.00K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.92M | 2.29M | 4.49M | 4.35M | 3.93M |
|
|
|||||
| Common Stock & APIC | 42.21M | 41.63M | 41.88M | 40.29M | 40.17M |
| Retained Earnings | -37.00M | -36.03M | -38.03M | -36.08M | -35.49M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.20M | 5.60M | 3.85M | 4.21M | 4.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.20M | 5.60M | 3.85M | 4.21M | 4.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.72M | 2.64M | 2.78M | 2.48M | 2.21M |
| Total Equity | 7.93M | 8.24M | 6.63M | 6.69M | 6.89M |
|
|
|||||